Fora Capital, LLC Natera, Inc. Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$59.21 - $92.9 $496,594 - $779,152	8,387 New	8,387 $767,000
Q4 2022 Feb 08, 2023	BUY	$34.17 - $47.91 $283,474 - $397,461	8,296 New	8,296 $333,000
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $14,370 - $19,993	-167 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $92,750 - $126,101	-1,014 Reduced 85.86%	167 $17 Million
Q4 2020 Feb 12, 2021	SELL	$66.66 - $111.74 $72,659 - $121,796	-1,090 Reduced 48.0%	1,181 $117,000
Q3 2020 Nov 13, 2020	SELL	$45.89 - $72.67 $238,123 - $377,084	-5,189 Reduced 69.56%	2,271 $164 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $196,645 - $371,955	7,460 New	7,460 $372 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.